Egret Therapeutics
Pre-clinicalDevelops small molecule therapies targeting neurological disorders including depression and cognitive impairment.
Founded
2021
Focus
NeuroscienceSmall Molecules
About
Develops small molecule therapies targeting neurological disorders including depression and cognitive impairment.
Funding History
1Total raised: $90M
Seed$90MThird Rock VenturesApr 15, 2023
Company Info
TypePrivate
Founded2021
LocationCambridge, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile